Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 300,852 | 14,632 | N/A | 1,838,000 | 544,000 |
| Marketable Securities | 44,462 | N/A | N/A | N/A | N/A |
| Receivables | N/A | N/A | N/A | 386,000 | 402,000 |
| Inventories | N/A | N/A | N/A | 445,000 | 597,000 |
| Other current assets | 0 | 0 | 0 | 318,000 | 389,000 |
| TOTAL | $349,087 | $14,759 | $N/A | $2,987,000 | $1,932,000 |
| Non-Current Assets | |||||
| PPE Net | 1,946 | 1,486 | N/A | 7,121,000 | 8,347,000 |
| Investments And Advances | 0 | 0 | 0 | 0 | 190,000 |
| Intangibles | 0 | 0 | 0 | 822,000 | 859,000 |
| Other Non-Current Assets | 2,301 | 191 | 0 | 2,123,000 | 131,000 |
| TOTAL | $4,247 | $1,677 | $N/A | $10,066,000 | $9,527,000 |
| Total Assets | $353,334 | $16,436 | $N/A | $13,053,000 | $11,459,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 201,000 | 80,000 |
| Accounts payable and accrued liabilities | 3,440 | 1,256 | 0 | 332,000 | 292,000 |
| Accrued Expenses | 7,527 | 1,102 | N/A | 214,000 | 199,000 |
| Other current liabilities | N/A | N/A | N/A | 72,000 | 135,000 |
| TOTAL | $10,967 | $2,358 | $N/A | $916,000 | $809,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 8,778,000 | 7,129,000 |
| Other Non-Current Liabilities | 0 | 42 | 0 | 1,319,000 | 576,000 |
| TOTAL | $N/A | $42 | $N/A | $10,098,000 | $7,731,000 |
| Total Liabilities | $10,967 | $2,400 | $N/A | $11,014,000 | $8,540,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,458 | N/A | N/A | N/A | N/A |
| Common Shares | 5 | 1 | N/A | 1,000 | 1,000 |
| Retained earnings | -79,183 | -19,746 | N/A | -1,927,000 | -686,000 |
| Other shareholders' equity | -27 | 27,429 | 0 | 418,000 | 417,000 |
| TOTAL | $342,367 | $14,036 | $N/A | $2,039,000 | $2,919,000 |
| Total Liabilities And Equity | $353,334 | $16,436 | $0 | $13,053,000 | $11,459,000 |